Foundation invites nominations for S R Jindal Prize 2012

[email protected] (CD Network)
April 28, 2012

Bangalore, April 28: Sitaram Jindal Foundation has invited nominations till May 16, 2012 for S R Jindal Prize 2012. The S R Jindal Prize 2012 will be announced for 7 categories in 2012 with awardees in each category to receive Rs 1 Crore. The award has been instituted last year to accolade exceptional service of current significance rendered by individuals or organisations for the welfare of Indian citizens in the country.

Sitaram Jindal Foundation also announced the constitution of a Screening Committee comprising of eminent persons of high integrity. The primary duty of the Screening Committee would be to scrutinize the applications received for S R Jindal Prize, 2012 before placing them before the Jury. Mrs. Jaiwanti Sheokand, Chairperson of the Screening Committee is a retired IAS officer, formerly Special Secretary to Environment Dept., Govt. of Haryana. Shri S.C. Jain, the Secretary of the Prize Secretariat is the Member Secretary of the Screening Committee. Shri S.C.Jain is a retired IAS officer and former Director, Rural Development, Govt of Haryana.

sjf

The Foundation has honoured 27 outstanding personalities, including APJ Abdul Kalam, N Santosh Hegde and Anna Hazare, by bestowing S R Jindal Prizes 2011 at a glittering Ceremony held in February this year. Those honoured included Individuals and Institutions who are beacons of selfless service to the society with prize money of Rs. 7.30 Crores.

The S R Jindal Prizes 2012 will be bestowed for the following seven categories: a) Agriculture, Rural Development & Poverty Alleviation; b) Healthcare – including drugless healing and Naturecare; c) Education – with emphasis on moral upliftment; d) Science, Technology and Environment; e) Peace, Social Harmony and Social Development; f) Crusade against Corruption; and g) Exemplary Service to mankind in any field.

The Foundation is also in the process of finalizing the jury for S R Jindal Prizes 2012 which will be comprising of eminent persons of extremely integrity headed by a retired Chief Justice, which will be announced shortly.

Patron of Sitaram Jindal Foundation & CMD of Jindal Aluminum, Dr. Sitaram Jindal's vision is “The most practical and meaningful way to give back to society, I feel, is to bring hope to the poor and downtrodden in distress. It is imperative that the society acknowledges the contribution of selfless workers working silently and honours them with the amount of respect they deserve, so that others are inspired to take the cause ahead. It is with this objective in view that the Foundation decided to institute the “S R Jindal Prize”.

Dr. Sitaram Jindal has set aside Rs. 125 Crores last year to form a corpus of funds for creating a perpetual Prize, to honour the deserving, year after year. Such perpetual financial stability of Prize Schemes is uncommon except in rare cases like the Nobel Prize.

The selection of the awardees shall be done through a stringent 3 tier process, consisting of appraisal, screening and final selection by the Jury. The nominations will be adjudicated by the Jury through a process independent of the working of the Foundation. The Prize Scheme had attracted close to 2000 nominations in the first year of its launch in 2011. Nominations received last year are also eligible for the prizes this year. Details of all nominations received are available at the prize website. For nominations sent in last year the nominator or nominee may only send in additional information in respect of such nomination quoting their nomination number.

Established in the year 1969, the Sitaram Jindal Foundation is an apolitical, non-religious and charitable trust in the field of education, health and social service. The foundation, besides extending financial support to other charitable institutions, has also directly set up several educational institutions and hospitals. The Foundation also assists the poor and deserving students through scholarships.


Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 15,2020

Bengaluru, Apr 15: As many as 17 new positive cases of COVID-19 have been reported in Karnataka, taking the total number of cases in the state to 277, including 75 discharged and 11 deaths, the state government said on Wednesday.

Of the 17 new cases, nine are workers of a pharmaceutical company in Mysuru, the government stated.

Meanwhile, a 65-year-old from Chikkaballapur, who had tested positive for COVID-19, lost his life on Wednesday.

"He was referred to a Bengaluru hospital with complaints of H1N1 positive, Chronic Obstructive Pulmonary Disease with obstructive sleep apnea and a past history of diabetes and hypertension," the government stated.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 17,2020

Kasaragod, Apr 17: Even as this district continue to remain in the high-alert red zone category of Covid-19, Kasaragod has slowly but steadily been limping back to restraint level of the pandemic from a possible slipping into a stage-3 of community spread early this month.

Thanks to the stringent and committed measures implemented by the district administration crisscross the district besides total isolation of few localities by enforcing triple lockdown.

The district had been a Covid-19 hotspot ever since an NRI who returned from the Gulf violated quarantine protocol and travelled wide and far by meeting and contacting with several people including two MLAs of the district. That apart the irresponsible attitude of the people who broke the rules of quarantine and lockdown norms also made things go from bad to worse resulting in contributing for a near-half of the total positive cases in the state at the beginning of April.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.